MedTrace Logo

Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging

NCT02203136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2019-05-22

No results posted yet for this study

Summary

The goal of this research study is to improve detection of cancer outside of the bladder through genetic testing and improved imaging.

Conditions

Interventions

PROCEDURE

Tissue Biopsy

During bladder cancer surgery, tissue specimen taken for molecular profiling.

PROCEDURE

Magnetic Resonance Imaging (MRI)

3 Tesla pelvic magnetic resonance imaging (MRI) performed four weeks after bladder cancer surgery.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Neema Navai, MD · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-25
Primary Completion
2019-05-16
Completion
2019-05-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02203136 on ClinicalTrials.gov